| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2009-09-02 14:40:18 |
| Versijas komentārs | |
| Teksts |
Olainfarm is actively taking measures to diversify its sales markets.
Share of sales to Russia in overall sales of Olainfarm by the end of this year could reach 50% to 55%, therefore the company is taking targeted measures to diversify its sales markets, said Valerijs Maligins, Chairman of Olainfarm’s Management Board.
Olainfarm plans to develop its registration efforts in Albanian, Kosovan, Vietnamese, Serbian, Romanian, Bulgarian and Polish markets, which fit well for company’s products and product documentation.
Olainfarm has already opened a representative office in Vietnam and plans to complete the registration of one or several products in that market by the end of the year. “Vietnam is the first country in Southeast Asia that we want to enter. If this attempt is successful then we will apply this experience to Indonesia, Malaysia, and other countries of the region. At the same time we are working on registration of four products in Albania and Romania. Our main effort as far as new markets are concerned is now focused on Balkans and Vietnam. Possibly a representative office of Olainfarm in Serbia’s capital Belgrade will be opened”, says Valerijs Maligins.
JSC Olainfarm is one of the biggest companies in the Baltic States with more than 35 years of experience in production of medicines and chemical and pharmaceutical products. The basic principle of Company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Currently the products of JSC Olainfarm are being exported to more than 30 countries worldwide, including the Baltics, Russia, CIS, Scandinavian and other Western European countries, Asia and the USA.
Information prepared by
Salvis Lapins
JSC "Olainfarm"
Deputy CFO
tel. +371 6 7013717,
cell: + 371 2 6448873
fax. + 371 6 7013777
|
| Pielikumi |
|